Search Results
Oct 20, 2025, 08:00 ET HealthVerity and Claritas Rx announce strategic partnership to unlock more actionable real-world insights for commercial, RWE, and HEOR teams
About Claritas Rx Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. By uniting the most complete
More news about: HealthVerity, Inc.
Oct 20, 2025, 08:00 ET The Jackson Laboratory acquires New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patients
equipping scientists worldwide to uncover disease mechanisms earlier and advance progress toward therapies for Alzheimer's, cancer, diabetes, Parkinson's, rare diseases and more BAR HARBOR, Maine and NEW YORK,
More news about: The Jackson Laboratory
Oct 20, 2025, 08:00 ET RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor
cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers including HUMIRA, your chance
More news about: AbbVie
Oct 20, 2025, 07:30 ET Endo Launches First and Only Generic Version of RAVICTI® (glycerol phenylbutyrate) Oral Liquid in the United States
The generic formulation offers a new option for both adult and pediatric patients managing rare metabolic conditions. This launch represents a key first-to-market generic
More news about: Endo USA, Inc.
Oct 20, 2025, 07:00 ET Milvus Advanced Raises Seed Round to Scale Industrial-Scale Substitution of Critical Elements With Next-Generation Nanoalloy Technologies
sectors rely heavily on rare metals such as platinum group metals: scarce, expensive, and sourced from geopolitically fragile regions. This creates cost volatility, insecure supply chains, and environmental damage. Milvus eliminates these constraints by recreating the properties of rare metals using sustainable,
More news about: Milvus Advanced
Oct 20, 2025, 07:00 ET Andel Raises $4.5M for Its Employer-Supported Medication Marketplace
payers face severe headwinds and patient access is at risk, Andel offers a better path forward for patients, payers, and providers. Jay and Ritu bring a rare mix of entrepreneurial execution and deep industry expertise, and Springboard Health Angels sees extraordinary promise in what they are building." Said
More news about: Andel Co-op, Inc.
Oct 20, 2025, 07:00 ET Novo Nordisk to present new data in oral semaglutide 25 mg (Wegovy® in a pill*) and obesity pipeline at ObesityWeek® 2025
heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and
More news about: NOVO NORDISK INC.
Oct 20, 2025, 07:00 ET Novo Nordisk to present new data in oral semaglutide 25 mg (Wegovy® in a pill*) and obesity pipeline at ObesityWeek® 2025
heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and
More news about: NOVO NORDISK INC.
Oct 20, 2025, 06:12 ET Battery Recycling Market to Reach $77.1 billion, Globally, by 2034 at 11.2% CAGR: Allied Market Research
proposals), while maintaining high recovery rates for nickel, cobalt, and manganese at 98%. New targets of 98% are also set for copper, aluminum, and rare earth metals. Export of Recycled Batteries to Countries with Material Shortages
More news about: Allied Market Research
Oct 20, 2025, 06:02 ET Battery Recycling Market to Reach $77.1 billion, Globally, by 2034 at 11.2% CAGR: Allied Market Research
proposals), while maintaining high recovery rates for nickel, cobalt, and manganese at 98%. New targets of 98% are also set for copper, aluminum, and rare earth metals. Export of Recycled Batteries to Countries with Material Shortages
More news about: Allied Market Research
Oct 20, 2025, 06:00 ET IDEAYA Biosciences Reports Positive Median Overall Survival Data from Phase 2 Trial of the Darovasertib and Crizotinib Combination in First-line Metastatic Uveal Melanoma at the 2025 Society for Melanoma Research Congress
Skin Cancer Research for Sarah Cannon Research Institute and principal investigator on the trial. Metastatic uveal melanoma is a rare and aggressive form of ocular cancer with poor prognosis, where historical median OS reported in published meta-analysis from patients in the treatment
More news about: IDEAYA Biosciences, Inc.
Oct 20, 2025, 05:36 ET Battery Recycling Market to Reach $77.1 billion, Globally, by 2034 at 11.2% CAGR: Allied Market Research
proposals), while maintaining high recovery rates for nickel, cobalt, and manganese at 98%. New targets of 98% are also set for copper, aluminum, and rare earth metals. Export of Recycled Batteries to Countries with Material Shortages
More news about: Allied Market Research
Oct 20, 2025, 05:00 ET FDA Grants Orphan Drug Designation to Cellenkos' CK0803 Tregs for Treatment of Amyotrophic Lateral Sclerosis
This designation supports the development of medicines for rare disorders that affect fewer than 200,000 people in the U.S, and qualifies a company for incentives, including tax credits, exemptions from certain FDA
More news about: Cellenkos, Inc.
Oct 20, 2025, 02:37 ET Immunotherapy After Surgery Shows Promise in Treating Rare, Aggressive Skin Cancer
Oct. 20, 2025 /PRNewswire/ -- A drug that harnesses the immune system to attack cancer cells has proved successful in preventing a rare and aggressive form of skin cancer from spreading to other organs when given immediately after surgery, a new study shows.
More news about: NYU Langone Health System
Oct 20, 2025, 00:06 ET Une nouvelle ère pour les spiritueux de luxe commence : Les Jardins d'Arménie font leurs débuts à Monaco
s'agit d'un héritage culturel et d'un savoir-faire transmis de génération en génération. Avoir l'honneur de guider cette dégustation est un privilège rare", a déclaré Bruno Scavo, sommelier, journaliste Vins & Gastronomie. A propos des Jardins d'Arménie
More news about: Jardins d’Arménie
Oct 19, 2025, 16:01 ET Sobi announces revised full year outlook and advances publication of the Q3 2025 financial report
Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK
More news about: Swedish Orphan Biovitrum AB
Oct 19, 2025, 15:59 ET Sobi announces revised full year outlook and advances publication of the Q3 2025 financial report
Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK
More news about: Swedish Orphan Biovitrum AB
Oct 19, 2025, 02:00 ET Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens,
More news about: CARsgen Therapeutics
Oct 18, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers - SVRA
Savara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. The Company's lead product candidate is MOLBREEVI (also referred to as "molgramostim"), an inhaled granulocyte-macrophage colony-stimulating
More news about: Pomerantz LLP
Oct 17, 2025, 17:39 ET FDA approves Novo Nordisk's oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event
heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and
More news about: Novo Nordisk
Oct 17, 2025, 17:15 ET FDA approves Novo Nordisk's oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event
heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and
More news about: Novo Nordisk
Oct 17, 2025, 16:45 ET SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit
lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) the MOLBREEVI (a clinical trial for the treatment of a rare lung disease) Biologics License Application ("BLA") lacked sufficient information regarding MOLBREEVI's chemistry, manufacturing, and/or controls; (2)
More news about: THE ROSEN LAW FIRM, P. A.
Oct 17, 2025, 16:25 ET Liza Minnelli to Present Janet Jackson with the 2025 ICON Award at the Gala of the Stars Benefiting Dancers Against Cancer
feet, now returns to honor another boundary-breaking trailblazer. The union of these two legendary women—each redefining artistry in her own era—marks a rare and emotional convergence of music, movement, and enduring influence. Australian performer BP Major, Ms. Minnelli's Artistic
More news about: Dancers Against Cancer
Oct 17, 2025, 16:00 ET FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of
More news about: Amgen
Oct 17, 2025, 12:27 ET SIGMA LITHIUM ADDED TO MORGAN STANLEY NATIONAL SECURITY INDEX
First Quantum Minerals (copper), Cameco Corp (uranium), MP Materials (rare earths), Lithium Americas (lithium), Centrus Energy Corp (uranium), NioCorp Developments (rare earths), USA Rare Earth (rare earths), Ivanhoe Electric (rare earths), among others. The index also includes Tesla (technology, batteries).
More news about: Sigma Lithium Corporation